Overview

The actively managed equity fund focuses on bottom-up active stock selection across Global markets.

The fund aims to invest in selected Global companies, that trade below their long-term fair value based on fundamental analysis.

The fund is diversified across countries and sectors.

It is a high conviction portfolio based on best-ideas across Global equity markets with a clear Value bias.

Benefits

Easy access to Global equity markets.

The portfolio may deviate considerably from the reference index in order to increase outperformance potential.

The fund managers leverages off a network of equity analysts around the globe.

Investors benefit from the fact that UBS is one of the few asset managers with a truly global investment platform.

Risks

The fund invests in equities and may therefore be subject to high volatility. This requires an elevated risk tolerance and capacity. The value of a unit may fall below the purchase price. The value of a unit may be influenced by currency fluctuations. Every fund reveals specific risks, a detailed and comprehensive list of risk descriptions can be found in the prospectus. This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.

Features

Product category
Equity
Global
Product domicile
Luxembourg
Portfolio management
UBS SA国际传谋 (UK) Ltd., London
Fund management
UBS SA国际传谋 (Europe) S.A., Luxembourg
Custodian bank
UBS Europe SE, Luxembourg Branch
Representative for products established under foreign law
UBS Fund Management (Switzerland) AG
Day of inception
March 20, 2024
Currency of account
USD
Close of financial year
September 30
SFDR Classification
Art.8
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
0.04% p.a.
Flat fee
0.00% p.a.
Management fee
0.00% p.a.
Total expense ratio (TER)
0.04% p.a.
Minimum investment
n.a.
Reference Index / Benchmark
MSCI World (net div. Reinv.) in USD
Cut-Off Time
15:00h(CET)
Securities no.
132327421
ISIN
LU2741903889
Bloomberg Ticker
UBSGVIX LX

Performance and Prices

Percentage growth

as of April 23, 2026
Cumulative
USD(%) CHF(%) EUR(%)
YTD 8.80 7.62 9.12
1M
3M
6M
1Y
2Y 47.66 27.09 34.89
3Y
5Y
ø p.a.5Y 21.51 12.74 16.14

Current data

Net asset value 23.04.2026 USD 150.39
High - last 12 months 17.04.2026 USD 151.20
Low - last 12 months 25.04.2025 USD 105.14
Assets of the unit class in mn 23.04.2026 USD 4.02
Total product assets in mn 23.04.2026 USD 4.76
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 31.03.2026 10.56% n.a.
Sharpe Ratio 31.03.2026 0.93 n.a.
Risk Free Rate 31.03.2026 4.55% 3.51%

Structures

By the 10 largest positions (in %, as of March 31, 2026)

 
 
Alphabet Inc 5.56
Amazon.com Inc 4.62
Bristol-Myers Squibb Co 3.32
NVIDIA Corp 3.22
Glencore PLC 2.77
Microsoft Corp 2.77
TotalEnergies SE 2.73
Labcorp Holdings Inc 2.31
Shin-Etsu Chemical Co Ltd 2.19
Micron Technology Inc 2.15

Fees

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Australia
Institutional Only*
Luxembourg
Registered
Switzerland
Registered

Literature

Brochures
Document type
Document Language
Fact Sheet
Swiss Climate Scores Report
ASIP ESG Report
Fact Sheet - Equity
Fact Sheet - Global
Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Statutes / Management regulations
ESG Disclosure
SFDR Pre-Contractual Annex
Annual and semi-annual report (accounting on September 30)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.